8 things to know about the Asia-Pacific minimally invasive spine device market

A new Reporterlink analysis examines the Asia Pacific minimally invasive spine surgery device market, which is expected to grow over the next several years.

Advertisement

Here are eight key takeaways from the report:

 

•    The Asia Pacific and emerging MIS spinal device market will both grow at a double-digit rate through the forecast period.
•    Young surgeons in the market see minimally invasive procedures as the future of their subspecialty.
•    There is a huge demand in the market for back pain treatment and more patients are becoming aware of the advantages of minimally invasive procedures when compared with open surgery.
•    The increased aging population will also contribute to the minimally invasive spine device market expansion.
•    Growth is expected to slow at some point through 2020 with increased penetration of minimally invasive procedures in the traditional fusion and motion preservation markets.
•    The minimally invasive interbody fusion and thoracolumbar fixation markets are also expected to grow through 2020.
•    The lateral lumbar interbody fusion procedures are expected to drive rapid growth in the minimally invasive interbody fusion market.

 

More articles on orthopedic devices:
80 things to know about orthopedic device company financial reports
Aurora Spine ramping up for big second half of 2014 — 5 things to know
Surgical Frontiers closes $7M funding: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new product launches and leadership appointments, here are seven key headlines from Stryker in the first quarter of 2026.…

  • Xtant Medical’s 2025 revenue reached $133.9 million, a 14% increase year over year, according to financial results posted March 31.…

Advertisement

Comments are closed.